Search research articles
Contact Us
Filters
Showing results (111-120 of 302) with videos related to
Page
of 31
Sort By:
Journal of Preventive Medicine and Hygiene
|
November 23, 2022
Indirect hyperbilirubinemia and jaundice during chronic hepatitis C in an HIV-infected patient treated with glecaprevir/pibrentasvir (GLE/PIB) and antiretroviral therapy (ART). The first reported case in Italy
Antonio Mastroianni, Valeria Vangeli, Sonia Greco, et al.
Frontiers in Microbiology
|
April 5, 2021
On the SARS-CoV-2 "Variolation Hypothesis": No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases
Mattia Trunfio, Bianca Maria Longo, Francesca Alladio, et al.
Journal of Neurovirology
|
March 2, 2026
Serum but not cerebrospinal fluid biomarkers are associated with domain-specific cognitive performance in PWH
Elisa Vuaran, Mattia Trunfio, Marco Russo, et al.
The Journal of Antimicrobial Chemotherapy
|
March 12, 2011
Pharmacokinetics and safety of the co-administration of the antiretroviral raltegravir and the lipid-lowering drug ezetimibe in healthy volunteers
Akil Jackson, Antonio D'Avolio, Victoria Watson, et al.
Therapeutic Drug Monitoring
|
July 27, 2002
Pharmacokinetic evaluation of indinavir and indinavir/ritonavir-containing antiretroviral regimens in a clinical setting
Marta Boffito, Stefano Bonora, Riccardo Raiteri, et al.
Journal of the International AIDS Society
|
November 14, 2014
Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice
Silvia Costarelli, Alessandro Cozzi-Lepri, Giuseppe Lapadula, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
May 22, 2015
A LC-MS method to quantify tenofovir urinary concentrations in treated patients
Marco Simiele, Chiara Carcieri, Amedeo De Nicolò, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 5, 2014
Cerebrospinal fluid inhibitory quotients of antiretroviral drugs in HIV-infected patients are associated with compartmental viral control
Andrea Calcagno, Marco Simiele, Maria Chiara Alberione, et al.
Therapeutic Drug Monitoring
|
January 30, 2004
Lopinavir protein binding in vivo through the 12-hour dosing interval
Marta Boffito, Patrick G Hoggard, W Edward Lindup, et al.
Biomedical Optics Express
|
October 1, 2019
Adaptive optics in the mouse eye: wavefront sensing based vs. image-guided aberration correction
Daniel J Wahl, Pengfei Zhang, Jacopo Mocci, et al.
Page
of 31
Search research articles
Search
Showing results (111-120 of 302) with videos related to
Sort By:
Page
of 31
Journal of Preventive Medicine and Hygiene
|
November 23, 2022
Indirect hyperbilirubinemia and jaundice during chronic hepatitis C in an HIV-infected patient treated with glecaprevir/pibrentasvir (GLE/PIB) and antiretroviral therapy (ART). The first reported case in Italy
Antonio Mastroianni, Valeria Vangeli, Sonia Greco, et al.
Frontiers in Microbiology
|
April 5, 2021
On the SARS-CoV-2 "Variolation Hypothesis": No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases
Mattia Trunfio, Bianca Maria Longo, Francesca Alladio, et al.
Journal of Neurovirology
|
March 2, 2026
Serum but not cerebrospinal fluid biomarkers are associated with domain-specific cognitive performance in PWH
Elisa Vuaran, Mattia Trunfio, Marco Russo, et al.
The Journal of Antimicrobial Chemotherapy
|
March 12, 2011
Pharmacokinetics and safety of the co-administration of the antiretroviral raltegravir and the lipid-lowering drug ezetimibe in healthy volunteers
Akil Jackson, Antonio D'Avolio, Victoria Watson, et al.
Therapeutic Drug Monitoring
|
July 27, 2002
Pharmacokinetic evaluation of indinavir and indinavir/ritonavir-containing antiretroviral regimens in a clinical setting
Marta Boffito, Stefano Bonora, Riccardo Raiteri, et al.
Journal of the International AIDS Society
|
November 14, 2014
Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice
Silvia Costarelli, Alessandro Cozzi-Lepri, Giuseppe Lapadula, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
May 22, 2015
A LC-MS method to quantify tenofovir urinary concentrations in treated patients
Marco Simiele, Chiara Carcieri, Amedeo De Nicolò, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 5, 2014
Cerebrospinal fluid inhibitory quotients of antiretroviral drugs in HIV-infected patients are associated with compartmental viral control
Andrea Calcagno, Marco Simiele, Maria Chiara Alberione, et al.
Therapeutic Drug Monitoring
|
January 30, 2004
Lopinavir protein binding in vivo through the 12-hour dosing interval
Marta Boffito, Patrick G Hoggard, W Edward Lindup, et al.
Biomedical Optics Express
|
October 1, 2019
Adaptive optics in the mouse eye: wavefront sensing based vs. image-guided aberration correction
Daniel J Wahl, Pengfei Zhang, Jacopo Mocci, et al.
Page
of 31